Novel substituted tetrahydrotriazaacenaphthylene derivatives as potent CRF1 receptor antagonists
作者:Gabriella Gentile、Romano Di Fabio、Francesca Pavone、Fabio Maria Sabbatini、Yves St-Denis、Maria Grazia Zampori、Giovanni Vitulli、Angela Worby
DOI:10.1016/j.bmcl.2007.06.077
日期:2007.9
Corticotropin-releasing factor (CRF), a 41 amino acid peptide neurohormone synthesised by specific hypothalamic nuclei in the brain, is implicated in stress-related function. Antagonism of CRF1 receptors is an attractive therapeutic approach for the treatment of depression and anxiety. Unsaturated tetrahydrotriazaacenaphthylenes of general structure 3 have been identified as potent and selective CRF1 receptor antagonists with a suitable oral pharmacokinetic profile. (c) 2007 Elsevier Ltd. All rights reserved.